MOD3 Pharma Revenue
Pharmaceutical Manufacturing • 
Montville, New Jersey, United States • 11-20 Employees
MOD3 Pharma revenue & valuation
| Annual revenue | $1,112,215 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $3,600,000 |
| Total funding | No funding |
Key Contacts at MOD3 Pharma
Amy Sturmer-Margulis
Director Bioanalytical Development
Andy Rasums
Director Of Quality Assurance
Mod3 Inc
Owner
Company overview
| Headquarters | 83 Fulton St., Boonton, NJ 07005, US |
| Websites | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Product Development, Oindp, Clinical Supplies, Formulation Development, Analytical Method Development, Cgmp Manufacturing, Clinical Labeling, Cmc Consulting, Finished Product Release Testing, Gmp Stability Studies, Orally Inhaled & Nasal Drug Products, Regulatory Writing – Module 3, Spray Drying & Particle Engineering |
| Founded | 2013 |
| Employees | 11-20 |
MOD3 Pharma Email Formats
MOD3 Pharma uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@enterisbiopharma.com), used 75% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@enterisbiopharma.com | 75% |
{first name}{last name} | johndoe@enterisbiopharma.com | 25% |
About MOD3 Pharma
MOD3 Pharma combines decades of CMC experience with a laser focus on Orally Inhaled and Nasal Drug Products (OINDP) to transform your investigational drug into a clinic ready product. Using a stage appropriate methodology within the Module 3 framework, our experts work with you to manage risk, mitigate delay and reduce cost while ensuring your OINDP product's quality, safety, and efficacy. Risk. Time. Cost. The trifecta of challenges that can keep you awake at night. Because your project matters – it really matters, not just to you, but to the patients that will rely on your therapy to make their lives better. Specifically supporting clients working within phases 1&2 of clinical trials, MOD3 Pharma’s capabilities include spray drying, semi-automated filling and assembly for single dose powder and liquid nasal systems, bi-dose and multidose nasal devices. This service proposition uniquely fills the gap for organizations needing early phase clinical supplies.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
MOD3 Pharma has 8 employees across 4 departments.
Departments
Number of employees
Funding Data
MOD3 Pharma has never raised funding before.
Spain
United Kingdom
Israel
Frequently asked questions
4.8
40,000 users
